Advertisement

Lichttherapie

  • Erhard Hölzle
  • Percy Lehmann
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Licht, also optische Strahlung, wird in der Dermatotherapie vor allem als ultraviolette Strahlung angewandt. Die wichtigsten therapeutischen Modalitäten umfassen Bestrahlungen mit UV-B (280–320 nm) oder Schmalspektrum-UV-B (311–313 nm), UV-A (320–400 nm) oder UV-A1 (340–400 nm) sowie die Kombination eines Photosensibilisators (meist Psoralene) mit UV-A-Strahlung im Sinne einer Photochemotherapie. In diesem Kapitel werden diese Verfahren erläutert sowie Indikationen, Dosierungsempfehlungen und Risiken beschrieben.

Literatur

Übersichten

  1. Breuckmann F, Gambichler T, Altmeyer P et al (2004) UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol 4:11CrossRefPubMedPubMedCentralGoogle Scholar
  2. Guidelines of care for phototherapy and photochemotherapy (1994) American Academy of Dermatology Committee on guidelines of care. J Am Acad Dermatol 31:643–648CrossRefGoogle Scholar
  3. Herzinger T, Berneburg M, Ghoreschi K et al (2016) S1-Leitlinie zur UV-Fototherapie und Photochemotherapie. J Dtsch Dermatol Ges 14:853–862CrossRefPubMedGoogle Scholar
  4. Krutmann J, Hönigsmann H, Elmets CA (2009) Dermatological phototherapy and photodiagnostic methods, 2. Aufl. Springer, BerlinGoogle Scholar
  5. Menter A, Korman NJ, Elmets CA (2010) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 62:114–135Google Scholar
  6. Nast A, Boehncke WH, Mrowietz U et al (2011) S3-Leitlinie zur Therapie der Psoriasis vulgaris. J Dtsch Dermatol Ges 9(Suppl. 2):S1–S104PubMedGoogle Scholar

UV-B-Phototherapie

  1. Asawanonda P, Nateetongrungsak Y (2006) Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol 54:1013–1018CrossRefPubMedGoogle Scholar
  2. Chen X, Yang M, Cheng Y, Liu GJ, Zhang M (2013) Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet. A photochemotherapy for psoriasis. Cochrane Database Syst Rev (10):CD009481Google Scholar
  3. Ibbotson SH, Bilsland D, Cox NH et al (2004) An up-date and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 151:283–297CrossRefPubMedGoogle Scholar
  4. Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation. J Am Acad Dermatol 42:245–253CrossRefPubMedGoogle Scholar
  5. Storbeck H, Hölzle E, Schürer N et al (1993) Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 28:227–231CrossRefPubMedGoogle Scholar

UV-A1-Phototherapie

  1. Kobyletzki G, Pieck C, Hoffmann K et al (1999) Medium-dose UVA-1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 41:931–937CrossRefGoogle Scholar
  2. Krutmann J, Diepgen TL, Luger TA et al (1998) High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 38:589–593CrossRefPubMedGoogle Scholar
  3. Sator PG, Radakovic S, Schulmeister K et al (2009) Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol 60:786–791CrossRefPubMedGoogle Scholar
  4. Schmidt T, Abeck D, Boeck K et al (1998) UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol (Stockh) 78:318–319CrossRefGoogle Scholar

Photochemotherapie

  1. Berneburg M, Herzinger T, Rampf J et al (2013) Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study. Br J Dermatol 169:704–708CrossRefPubMedGoogle Scholar
  2. Cox NH, Jones SK, Downey DJ et al (1987) Cutaneous and ocular side-effects of oral photochemotherapy; results of an 8-year-follow-up study. Br J Dermatol 116:145–152CrossRefPubMedGoogle Scholar
  3. Garritsen FM, Brouwer MW, Limpens J, Spuls PI (2014) Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol 170:501–513CrossRefPubMedGoogle Scholar
  4. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E et al (1999) Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 141:497–501CrossRefPubMedGoogle Scholar
  5. Henseler T, Wolff K, Hönigsmann H et al (1981) The European PUVA study (EPS) on oral 8-methoxypsoralen photochemotherapy of psoriasis. A cooperative study among 18 European centres. Lancet 1:853–857CrossRefPubMedGoogle Scholar
  6. Henseler T, Christophers E, Hönigsmann H et al (1987) Skin tumors in the European PUVA study: eight year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16:108–116CrossRefPubMedGoogle Scholar
  7. Lowe NJ, Weingarten D, Moly LS (1986) PUVA therapy for psoriasis: comparison of oral and bathwater delivery of 8-methoxypsoralen. J Am Acad Dermatol 14:754–760CrossRefPubMedGoogle Scholar
  8. McKenna KE, Whittaker S, Rhodes LE et al (2006) Evidence-based practice of photopheresis 1987–2001: a report of a workshop of the British Photodermatology Group and the U.K. Lymphoma Group. Br J Dermatol 154:7–20CrossRefPubMedGoogle Scholar
  9. Schwarz T (2005) Regulatory T cells induced by ultraviolet radiation. Int Arch Allergy Immunol 137:187–193CrossRefPubMedGoogle Scholar
  10. Stern RS, Liebman EJ, Vakeva L (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 90:1278–1284CrossRefPubMedGoogle Scholar

Erstbeschreiber

  1. Edelson R, Berger C, Gasparro F et al (1987) Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally-photoactivated 8-methoxypsoralen. N Engl J Med 316:297–303CrossRefPubMedGoogle Scholar
  2. El Mofty AM (1948) A preliminary report on the treatment of leukoderma with Ammi majus Linn. J Egypt Med Assoc 31:651–665Google Scholar
  3. Fischer T, Alsis J (1976) Treatment of psoriasis with methoxypsoralen bath and dysprosium lamps. Acta Derm Venereol (Stockh) 56:383–390Google Scholar
  4. Goeckermann WH (1925) The treatment of psoriasis. Northwest Med 24:229–231Google Scholar
  5. Ingram JT (1953) The approach to psoriasis. Br Med J II:591–594CrossRefGoogle Scholar
  6. Kerscher M, Volkenandt M, Plewig G, Lehmann P (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923CrossRefPubMedGoogle Scholar
  7. Krutmann J, Czech W, Diepgen T et al (1992) High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26:225–230CrossRefPubMedGoogle Scholar
  8. Mortazawi SA, Oberste-Lehn H (1973) Photosensibilisatoren und ihre therapeutischen Möglichkeiten. 1. Bericht. Z Haut Geschlechtskr 48:1–9PubMedGoogle Scholar
  9. Mutzhas MF, Hölzle E, Hofmann C et al (1981) A new apparatus with high radiation energy between 320–460 nm: physical description and dermatological applications. J Invest Dermatol 76:42–47CrossRefPubMedGoogle Scholar
  10. Parrish JA, Jaenicke KF (1981) Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76:359–362CrossRefPubMedGoogle Scholar
  11. Parrish JA, Fitzpatrick TB, Tanenbaum L et al (1974) Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 291:1207–1211CrossRefPubMedGoogle Scholar
  12. Van Weelden H, De La Faille HB, Young E et al (1988) A new development in UVB phototherapy of psoriasis. Br J Dermatol 119:11–19CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Universitätsklinik für Dermatologie und AllergologieKlinikum OldenburgOldenburgDeutschland
  2. 2.Zentrum für Dermatologie, Allergologie und Dermatochirurgie, DKG-Zertifiziertes Hautkrebszentrum, HELIOS Klinikum WuppertalUniversität Witten-HerdeckeWuppertalDeutschland

Section editors and affiliations

  • Thomas Ruzicka
    • 1
  1. 1.Klinik und Poliklinik für Dermatologie und AllergologieUniversität MünchenMünchenGermany

Personalised recommendations